| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 05/26/1999 | EP0917535A1 Neuroactive peptide |
| 05/26/1999 | EP0859785A4 Cyclic peptide analogs of somatostatin |
| 05/26/1999 | EP0833835A4 Obesity protein intermediates and their preparation and use |
| 05/26/1999 | EP0804459A4 Therapeutic compound - fatty acid conjugates |
| 05/26/1999 | EP0783316A4 Synthetic antibiotics |
| 05/26/1999 | EP0677117B1 Differentiation of htlv-i and htlv-ii using synthetic peptides |
| 05/26/1999 | EP0589993B1 Human p450 iid6 cytochrome-derived peptide fragments, anti peptide fragment antibodies, and applications thereof in the diagnosis of autoimmune hepatitis |
| 05/25/1999 | US5907784 Method of making multi-layer gate structure with different stoichiometry silicide layers |
| 05/25/1999 | US5906922 Delivery of nucleic acids |
| 05/25/1999 | CA1340555C Oral vaccines |
| 05/20/1999 | WO1999024462A2 Novel conjugates of rgd-containing peptides and endogenous carriers |
| 05/20/1999 | WO1999024076A2 Salicylate derivatized therapeutic and diagnostic agents |
| 05/20/1999 | WO1999024074A2 Novel conjugates of opioids and endogenous carriers |
| 05/20/1999 | WO1999016791A3 Compounds and methods for regulating cell adhesion |
| 05/20/1999 | WO1999007734A3 Hepatitis c inhibitor peptide analogues |
| 05/20/1999 | WO1999007733A3 Hepatitis c inhibitor peptides |
| 05/20/1999 | WO1998013007A8 Methods and compositions for lipidization of hydrophilic molecules |
| 05/20/1999 | CA2628053A1 Affinity markers for human serum albumin |
| 05/20/1999 | CA2309205A1 Novel conjugates of rgd-containing peptides and endogenous carriers |
| 05/19/1999 | EP0916680A2 Lantibiotic related to Actagardine, process of preparation and use thereof |
| 05/19/1999 | EP0916396A2 Combinatorial strategies for polymer synthesis |
| 05/19/1999 | EP0915969A1 Method for preventing hiv-1 infection of cd4+ cells |
| 05/19/1999 | EP0915908A1 Dolastatin pentapeptide derivatives and their use as antitumor agents |
| 05/19/1999 | EP0915700A1 Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors |
| 05/19/1999 | EP0605627B1 Immunoassay for identifying alcoholics and monitoring alcohol consumption |
| 05/18/1999 | CA1340544C Human tissue factor related dna segments, polypeptides and antibodies |
| 05/14/1999 | WO1999022758A1 Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent |
| 05/14/1999 | WO1999022756A1 Cell-permeable protein inhibitors of calpain |
| 05/14/1999 | WO1999011282A9 Compositions and methods for contraception in or sterilization of mammals |
| 05/14/1999 | WO1998014593A9 Human telomerase catalytic subunit |
| 05/12/1999 | EP0915099A1 Antiparallel oligopeptides and hydrophobically complementary oligopeptides, matrices containing them and use thereof in the purification and detection of subtypes of alpha interferon |
| 05/12/1999 | EP0914828A2 Use of des-aspartate-angiotensin I |
| 05/12/1999 | EP0914827A1 Ophthalmic drug compositions |
| 05/12/1999 | EP0914451A1 Il-1/tnf-alpha-activated kinase (itak), and methods of making and using the same |
| 05/12/1999 | EP0914344A1 ASSAY AND REAGENTS FOR QUANTIFYING hBNP |
| 05/12/1999 | EP0914334A1 Process and intermediates for the synthesis of lhrh antagonists |
| 05/12/1999 | EP0914333A1 Peptide derivatives |
| 05/12/1999 | EP0914331A1 Neuroactive peptides |
| 05/12/1999 | EP0914041A1 Methods and compositions for suppressing an immune response using major histocompatibility complex (mhc) class ii peptides |
| 05/12/1999 | EP0880357A4 Synthesis of conformationally restricted amino acids, peptides and peptidomimetics by catalytic ring closing metathesis |
| 05/12/1999 | EP0789710B1 Peptides for anti-allergy treatment |
| 05/12/1999 | EP0592553B1 Pla2 inhibitory compounds |
| 05/12/1999 | CN1216551A Novel peptides suitable for use in antigen specific immunosuppressive therapy |
| 05/11/1999 | US5902723 Selectively removing a nucleotide by cleavage at terminal ends with catalytic antibodies; identifying excision site and repeating process; for concurrent parallel sequence analysis |
| 05/06/1999 | WO1999021879A1 Cyclic peptides having broad spectrum antimicrobial activity |
| 05/06/1999 | WO1999021878A1 Interaction of alpha-conotoxin peptides with neuronal nicotinic acetylcholine receptors |
| 05/06/1999 | WO1999021877A1 Histogranin peptide and their analgesic use |
| 05/06/1999 | WO1999021571A1 Melanocortin receptor ligands and methods of using same |
| 05/06/1999 | EP0912758A1 Compositions and methods for screening antimicrobials |
| 05/06/1999 | EP0912733A1 Kappa/mu-like protein tyrosine phosphatase, ptp lambda |
| 05/06/1999 | EP0912730A2 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 05/06/1999 | EP0912603A1 A process for preparing certain aza cyclohexapeptides |
| 05/06/1999 | EP0912600A2 Peptidomimetic inhibitors of cathepsin d and plasmepsins i and ii |
| 05/06/1999 | EP0912546A1 Improved reservoir components |
| 05/06/1999 | EP0912195A1 Vaccine comprising antigens bound to carriers through labile bonds |
| 05/06/1999 | EP0787299A4 Receptor for a bacillus thuringiensis toxin |
| 05/06/1999 | EP0589004B1 Process for the determination of peptides corresponding to immunologically important epitopes of hcv |
| 05/06/1999 | CA2308115A1 Interaction of alpha-conotoxin peptides with neuronal nicotinic acetylcholine receptors |
| 05/06/1999 | CA2306754A1 Histogranin peptide and their analgesic use |
| 05/04/1999 | US5900237 Catalytic antibodies which hydrolyze primary amides and methods for eliciting such antibodies |
| 05/04/1999 | CA2248171A1 Improvements in or relating to detection of salmonella |
| 05/04/1999 | CA1340530C Synthetic pseudomonas aeruginosa pilin peptide and related vaccines and diagnostics |
| 05/04/1999 | CA1340523C Assay for in vitro measurement of amino-telopeptides of type 1 collagen |
| 04/29/1999 | WO1999021015A2 Affinity ligands, their production and use |
| 04/29/1999 | WO1999020651A1 Novel antifungal compounds |
| 04/29/1999 | WO1999020649A1 Spacer peptides and membranes containing same |
| 04/29/1999 | WO1999020295A1 Compositions and methods for promoting internalization and degradation of urokinase-type plasminogen activator |
| 04/29/1999 | WO1999002690A9 Systemin |
| 04/29/1999 | CA2306953A1 Compositions and methods for promoting internalization and degradation of urokinase-type plasminogen activator |
| 04/28/1999 | EP0911398A2 Phosphorylation epitopes of Tau protein for the diagnosis and treatment of Alzheimer's disease |
| 04/28/1999 | EP0911390A2 Protein kinases as tools for the diagnosis and treatment of Alzheimer's disease |
| 04/28/1999 | EP0910640A2 Peptides and peptidomimetic compounds affecting the activity of g-protein-coupled receptors by altering receptor oligomerization |
| 04/28/1999 | EP0910583A1 Thrombin inhibitors |
| 04/28/1999 | EP0910579A1 Compounds with growth hormone releasing properties |
| 04/28/1999 | EP0910576A2 Fusogenic liposomes |
| 04/28/1999 | EP0910575A1 Method for producing peptides |
| 04/28/1999 | EP0910574A2 Method for discovering novel anthelmintic compounds |
| 04/28/1999 | EP0910396A1 Isolated, nucleic acid molecules which code for gage tumor rejection antigen, the tumor rejection antigen, and uses thereof |
| 04/28/1999 | EP0910387A1 Apoptosis associated protein bbk |
| 04/28/1999 | EP0679092B1 Cytokine restraining agents |
| 04/27/1999 | US5897863 LHRH hormones |
| 04/24/1999 | CA2224066A1 Peptides as analgesics |
| 04/24/1999 | CA2219437A1 Peptides as analgesics |
| 04/22/1999 | WO1999019347A1 Synthetic genes with immunomodulatory effects |
| 04/22/1999 | WO1999018995A1 Immunogenic peptides from the hpv e7 protein |
| 04/22/1999 | WO1999018987A1 Ligand binding site of rage and uses thereof |
| 04/22/1999 | WO1999002565A3 Agent for the treatment and/or prophylaxis of microcirculation disorders |
| 04/22/1999 | DE19745583A1 New actagardine derivatives with extra N-terminal amino acid |
| 04/21/1999 | EP0909814A2 Use of protein kinases for the diagnosis and treatment of Alzheimer's disease |
| 04/21/1999 | EP0909275A1 Receptor derived peptides involved in modulation of response to ligand binding |
| 04/21/1999 | EP0692976B1 Chelating agents of the type xn 1?s 1?o 1? for radioactive isotopes, metal complexes thereof, and their use in diagnosis and therapy |
| 04/21/1999 | EP0565607B1 Protection group, compoud protected by this group and device for grafting the protection group onto the compound being protected |
| 04/21/1999 | CN1214692A Tumor rejection antigens presented by HLA-B44 molecules and uses thereof |
| 04/15/1999 | WO1999018127A1 Secreted proteins and polynucleotides encoding them |
| 04/15/1999 | WO1999018120A1 Deuterated cyclosporine analogs and their use as immunomodulating agents |
| 04/15/1999 | WO1999017792A1 Methods and compositions for treating rheumatoid arthritis |
| 04/15/1999 | WO1999017709A2 Methods and compositions for treating rheumatoid arthritis |
| 04/15/1999 | WO1999006440A8 Novel synthetic peptides with antimicrobial and endotoxin neutralizing properties for management of the sepsis syndrome |
| 04/15/1999 | WO1999005313A3 Method for typing of minor histocompatibility antigen ha-1 |
| 04/15/1999 | WO1999005172A3 Pharmaceuticals for modulating hormone responsiveness |